Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel - Scorecard - MDSpire

Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel

Novel therapy for dry eye market

  • February 10, 2026

  • 2 min

Share

Clinical Scorecard: Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel

At a Glance

CategoryDetail
ConditionDry Eye Disease
Key MechanismsCross-linked hyaluronic acid gel occludes the canalicular system to enhance tear film preservation.
Target PopulationPatients with dry eye disease, particularly those undergoing ocular surgical procedures.
Care SettingHealthcare professionals' offices across Europe.

Key Highlights

  • Lacrifill® provides long-lasting effects for up to six months.
  • Designed to temporarily block tear drainage for improved ocular surface lubrication.
  • Addresses challenges in patients with pre-existing ocular surface disease.

Guideline-Based Recommendations

Diagnosis

  • Assess ocular surface health in patients with dry eye disease.

Management

  • Utilize Lacrifill® for pre-and post-operative ocular surface health optimization.

Monitoring & Follow-up

  • Monitor tear film stability and patient satisfaction post-application.

Risks

  • Consider potential complications related to ocular surgery in patients with dry eye.

Patient & Prescribing Data

Patients with dry eye disease, especially those preparing for cataract or LASIK surgery.

Lacrifill® offers an individualized approach to managing dry eye symptoms.

Clinical Best Practices

  • Incorporate Lacrifill® into treatment plans for patients with dry eye disease.
  • Educate patients on the benefits of maintaining a stable ocular surface.

References

Original Source(s)

Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel

  • February 10, 2026

Related Content

Look Again! Demodex Blepharitis in Closer Focus

Why Demodex blepharitis deserves more attention – and how a quick diagnostic check can improve patient care

  • January 19, 2026

  • 7 min
Survey: 96% of Optometrists Assess Smoking Status

Survey finds widespread smoking status screening among optometrists in Wales following national training requirements.

Collagen: Emerging Importance in Dry Eye Therapy 

Advances in corneal science are reshaping how we understand – and potentially treat – dry eye disease